Join to view full profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Fax+1 626-301-8256
Dr. Rosenzweig is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2009 - 2011
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- Boston University Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Arizona College of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2011 - 2027
NC State Medical License 2021 - 2022
NY State Medical License 2009 - 2013
MA State Medical License 2004 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2014-2017
Clinical Trials
- A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
- The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
- Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma Start of enrollment: 2019 Dec 11
Publications & Presentations
PubMed
- BCMA CAR T for AL Amyloidosis After Plasmacytic Relapse of Lymphoplasmacytic Lymphoma.Nadia Al Haddad, Eugene Brailovski, Jacqueline Dela-Pena, Melinda Cook, Michael Rosenzweig
Ejhaem. 2026-06-01 - Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation.Rusha Bhandari, June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth
Diabetes, Obesity & Metabolism. 2026-03-01 - 1 citationsEchocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain Amyloidosis.Daniel Ng, Stephanie Wu, Huiyan Ma, Sarah Lee, Carlos Gomez Luna
Echocardiography. 2026-03-01
Press Mentions
Recommendations from FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical TrialsApril 9th, 2021
Novel Approaches Emerge in AL AmyloidosisApril 27th, 2018
Working TogetherOctober 10th, 2017
Grant Support
- Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African AmericansBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2027
- Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African AmericansBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
